These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23675047)

  • 1. Genetic studies of bone diseases: evidence for involvement of DNA damage response proteins in bone remodeling.
    Wang X; Li B
    Int J Biomed Sci; 2007 Dec; 3(4):217-28. PubMed ID: 23675047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis.
    Rasheed N; Wang X; Niu QT; Yeh J; Li B
    Hum Mol Genet; 2006 Jun; 15(12):1938-48. PubMed ID: 16644862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.
    Mukherjee A; Rotwein P
    Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.
    Wang X; Kua HY; Hu Y; Guo K; Zeng Q; Wu Q; Ng HH; Karsenty G; de Crombrugghe B; Yeh J; Li B
    J Cell Biol; 2006 Jan; 172(1):115-25. PubMed ID: 16380437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
    Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
    Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 control of bone remodeling.
    Liu H; Li B
    J Cell Biochem; 2010 Oct; 111(3):529-34. PubMed ID: 20589754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis.
    Ghosh-Choudhury N; Mandal CC; Das F; Ganapathy S; Ahuja S; Ghosh Choudhury G
    J Biol Chem; 2013 Aug; 288(34):24503-17. PubMed ID: 23821550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Role of Cyanidin-3-glucoside on the Differentiation of Bone Cells.
    Park KH; Gu DR; So HS; Kim KJ; Lee SH
    J Dent Res; 2015 Dec; 94(12):1676-83. PubMed ID: 26350961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rev-erbĪ± Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway.
    Kim K; Kim JH; Kim I; Seong S; Kim N
    Mol Cells; 2020 Jan; 43(1):34-47. PubMed ID: 31896234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
    Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
    J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblastic responses to TGF-beta during bone remodeling.
    Erlebacher A; Filvaroff EH; Ye JQ; Derynck R
    Mol Biol Cell; 1998 Jul; 9(7):1903-18. PubMed ID: 9658179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.